精确放疗在可根治非小细胞肺癌治疗中的作用

被引：6

作者：

朱广迎 ^{[1
]}

申文江 ^{[2
]}

机构：

[1] 北京大学临床肿瘤学院,北京肿瘤医院暨北京市肿瘤防治研究所放射治疗科,恶性肿瘤发病机制及转化研究教育部重点实验室

[2] 北京大学第一医院放射治疗科

来源：

中国肺癌杂志 | 2009年 / 12卷 / 04期

关键词：

精确放疗; 序贯放化疗; 生存率; 小细胞肺癌; 肺癌治疗; 同步放化疗; 非小细胞; 中位生存期; NSCLC;

D O I：

暂无

中图分类号：

R734.2 [肺肿瘤];

学科分类号：

100214 ;

摘要：

<正>肺癌是全球范围内最常见和最致命的恶性肿瘤,根据最新的统计,每年在所有的1090万新发恶性肿瘤病例中,肺癌占135万,每年670万因肿瘤死亡的病例中肺癌占118万。其中非小细胞肺癌(NSCLC)占肺癌患者总数的80%,其治疗方案的制定取决于TNM分期、患者体力状

引用

页码：261 / 267

页数：7

共 18 条

[1] 北京协和医院外科治疗肺癌生存率变化分析 [J].

张志庸 ;

郭峰 ;

崔玉尚 ;

李单青 ;

李力 ;

徐晓辉 ;

戈烽 ;

郭惠琴 ;

李泽坚 .

中国肺癌杂志, 2005, (02) :124-128

[2] 影响肺癌外科治疗预后因素的研究 [J].

李成继 ;

张汝刚 .

中国肺癌杂志, 2000, (06) :464-467

[3]

Optimal Beam Arrangement for Stereotactic Body Radiation Therapy of Lung Lesions: RTOG 0236 Criteria[J] . D. Lim,W.D. D’Souza,B. Yi,A. Mirmiran,A. Dhople.International Journal of Radiation Oncology, Biology, Physics . 2008 (1)

[4]

Treatment of Non-small Cell Lung Cancer Stage I and Stage II[J] . Walter J. Scott,John Howington,Steven Feigenberg,Benjamin Movsas,Katherine Pisters.Chest . 2007 (3)

[5] The IASLC lung cancer staging project [J].

Goldstraw, Peter .

JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (08) :S226-S227

[6]

Hypofractionated Stereotactic Radiotherapy (HypoFXSRT) for Stage I Non-small Cell Lung Cancer: Updated Results of 257 Patients in a Japanese Multi-institutional Study[J] . Hiroshi Onishi,Hiroki Shirato,Yasushi Nagata,Masahiro Hiraoka,Masaharu Fujino,Kotaro Gomi,Yuzuru Niibe,Katsuyuki Karasawa,Kazushige Hayakawa,Yoshihiro Takai,Tomoki Kimura,Atsuya Takeda,Atsushi Ouchi,Masato Hareyama,Masaki Kokubo,Ryusuke Hara,Jun Itami,Kazunari Yamada,Tsutomu Araki.Journal of Thoracic Oncology . 2007 (7 Su)

[7]

Phase I study to determine the MTD of paclitaxel given three times per week during concurrent radiation therapy for stage III non-small cell lung cancer*[J] . Anhui Shi,Tongtong An,Guangying Zhu,Rong Yu,Gang Xu,Xuyi Liu,Bo Xu.Current Medical Research and Opinion? . 2007 (5)

[8] High-dose radiotherapy in trimodality treatment of Pancoast tumors results in high pathologic complete response rates and excellent long-term survival [J].

Kwong, KF ;

Edelman, MJ ;

Suntharalingam, M ;

Cooper, LB ;

Gamliel, Z ;

Burrows, W ;

Hausner, P ;

Doyle, LA ;

Krasna, MJ .

JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2005, 129 (06) :1250-1257

[9]

Pr5 A randomized trial of radical surgery (S) versus thoracicradiotherapy (TRT) in patients (pts) with stage IIIA-N2 non-small cell lung cancer (NSCLC) after response to induction chemotherapy (ICT) (EORTC 08941)[J] . J. van Meerkbeeck,P. Van Schil,G. Kramer,C. Legrand,M. O’Brien,C. Manegold,A. Passioukov,G. Giaccone,N. van Zandwijk,T. Splinter.Lung Cancer . 2005

[10]

Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: a randomized study[J] . Petr Zatloukal,Lubos Petruzelka,Milada Zemanova,Libor Havel,Filip Janku,Libor Judas,Antonin Kubik,Evzen Krepela,Pavel Fiala,Ladislav Pecen.Lung Cancer . 2004 (1)

← 1 2 →